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Abstract. 
 
Tumor necrosis factor (TNF) is a cytokine 
produced by macrophages and T lymphocytes that
acts through two distinct receptors, TNFR1 (60 kD, 
CD120a) and TNFR2 (80 kD, CD120b), to affect cellu-
lar proliferation, differentiation, survival, and cell 
death. In addition to its proinﬂammatory actions in mu-
cosal tissue, TNF is important for liver regeneration. 
Keratin 8 (K8) and keratin 18 (K18) form intermediate 
ﬁlaments characteristic of liver and other single cell lay-
ered, internal epithelia and their derivative cancers. K8-
 
deﬁcient (K8
 
2
 
) mice, which escape embryonic lethality, 
develop inﬂammatory colorectal hyperplasia, mild liver 
abnormalities, and tolerate hepatectomy poorly. We 
show that normal and malignant epithelial cells deﬁ-
 
cient in K8 and K18 are 
 
z
 
100 times more sensitive to 
TNF-induced death. K8 and K18 both bind the cyto-
plasmic domain of TNFR2 and moderate TNF-induced, 
 
Jun NH
 
2
 
-terminal kinase (JNK) intracellular signaling 
 
and NF
 
k
 
B activation. Furthermore, K8
 
2
 
 and K18
 
2
 
 
mice are much more sensitive to TNF dependent, apop-
totic liver damage induced by the injection of con-
canavalin A. This moderation of the effects of TNF may 
be the fundamental function of K8 and K18 common to 
liver regeneration, inﬂammatory bowel disease, hepato-
toxin sensitivity, and the diagnostic, persistent expres-
sion of these keratins in many carcinomas.
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Abbreviations used in this paper:
 
 CHX, cycloheximide; ConA, con-
canavalin A; GST, glutathione S-transferase; JNK, Jun NH
 
2
 
-terminal ki-
 
nase; K8, keratin 8; K18, keratin 18; K8
 
2
 
, homozygous null 
 
Krt2-8
 
 tar-
geted mutation; K18
 
2
 
, homozygous null 
 
Krt1-18
 
 targeted mutation; TNF,
tumor necrosis factor; TNFR1, tumor necrosis factor receptor 1; TNFR2,
tumor necrosis factor receptor 2; TRAF, TNF receptor associated factors.
 
Introduction
 
Keratins are obligate heteropolymers composed of type I
(acidic, K9 through K20) and type II (neutral-basic, K1
through K8) subunits, which form filaments intermediate in
size between actin microfilaments and microtubules. Skin
abnormalities associated with mutations of specific epider-
mal keratins have provided strong evidence for a mechani-
cal function for the intermediate filaments of epidermis
(Fuchs and Weber, 1994). However, evidence for a mechan-
ical function for K8 and K18 is less compelling. K8 and K18
form intermediate filaments in trophectoderm, extraembry-
onic endoderm, and a variety of adult epithelial organs, in-
cluding liver, lung, kidney, pancreas, gastrointestinal tract,
mammary gland, and the cancers arising from these organs
(Oshima et al., 1996). In certain genetic backgrounds, most
K8-deficient (K8
 
2
 
)
 
1
 
 mice die well after the initial formation
of K8/K18 filaments in the trophectodermal layer of blasto-
cysts (Baribault et al., 1993). However, some K8
 
2
 
 and all
K18
 
2
 
 mice survive to adulthood (Baribault et al., 1994; Ma-
gin et al., 1998). K8
 
2
 
 mice that escape embryonic lethality
develop inflammatory colorectal hyperplasia similar to mice
deficient for the T cell receptor (Baribault et al., 1994). K8
 
2
 
hepatocytes generally fail to survive explantation after par-
tial hepatectomy (Loranger et al., 1997). Transgenic mice
that overexpress a disrupting, mutant form of K18 develop
mild chronic hepatitis and are more sensitive to the hepato-
toxins acetaminophen and griseofulvin (Ku et al., 1995,
1996). K18 binds several different cytoplasmic proteins,
however, the biological significance of these interactions are
not yet clear. (Omary and Ku, 1997). The inflammatory
bowel disease and liver abnormalities of mice with dis-
rupted or no K8 may involve proinflammatory and apop-
totic cytokines related to TNF. 
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Multiple members of the TNFR family of receptors
(TNFR1, Fas, DR3, TRAIL-R1, and TRAIL-R2) contain
a death domain that nucleates an apoptotic signaling com-
plex with binding of the adapter protein, FADD, activa-
tion of caspase 8 and downstream caspases that results in
cell death (Ashkenazi and Dixit, 1998). TNFR2 and other
members of the TNF receptor family (LT
 
b
 
R, CD40, and
CD30) lack a death domain, but also bind members of the
TNF receptor-associated factors (TRAF) family. TRAF3
is proapoptotic (VanArsdale et al., 1997), whereas TRAF2
and TRAF5 may inhibit apoptosis. One mechanism
of TNFR2 induction of apoptosis is through the induction
of TNF, which then stimulates TNFR1 (Grell et al., 1999).
TNF is also essential for liver regeneration (Yamada et al.,
1997). Here, we present evidence for a key role for K8 and
K18 in moderating the signaling and effects of TNF. This
moderating effect provides epithelial cells with resistance
to the apoptotic effects of TNF.
 
Materials and Methods
 
HR9 mouse parietal endodermal cells and the HR-1 and HR-7 clonal de-
rivatives and their culture conditions have been described (Kulesh et al.,
1989). A K8
 
2
 
 MDA MB435 human breast carcinoma cell line was re-
ceived from Mary Hendrix (University of Iowa). After transfection with
the LK444-K8 expression vector (Kulesh et al., 1989), multiple K8
 
1
 
 and
K8
 
2
 
 clones resistant to 400 
 
m
 
g/ml G418 were isolated. Expression of K8
mRNA in these clones restored K8/K18 filaments detected by immuno-
staining (data not shown). The K8
 
2
 
 epithelial cell line designated CMK8
was isolated from differentiated K8
 
2
 
 ES cells, subcloned, and rescued by
cotransfection with the EndoA gene and PGK-neo. Multiple K8 cytoskel-
eton positive and negative clones were then isolated and compared. For
drug sensitivity studies, the indicated concentrations of drugs were added
to near confluent cultures in complete medium containing 10% FBS. Cell
viability was determined by the MTT dye reduction assay (Green et al.,
1984).
pGEX vectors containing the cytoplasmic domains of CD40, LT
 
b
 
R,
 
HVEM, Fas, TNFR1, and TNFR2 were used for expressing and purifying
the corresponding glutathione 
 
S
 
-transferase (GST) fusion proteins (Mo-
sialos et al., 1995). pGEX-Fas and pGEX-TNFR2 were gifts from Dr. Ta-
kaaki Sato (Columbia University, New York). GST fusion proteins were
purified from 
 
Escherichia
 
 
 
coli
 
 (A0202) bacteria after induction in 0.1 mM
of isopropyl-
 
b
 
-
 
D
 
-thiogalactopyranoside for 3 h following the manufac-
turer’s instructions (Pharmacia Biotech). GST fusion protein binding ex-
periments were performed using 5 
 
m
 
g of each protein (Sato et al., 1995).
K8 and K18 proteins were synthesized and K18 was cleaved with caspase 6
after coupled transcription and translation reactions as described previ-
ously (Caulin et al., 1997).
HR9 cells on coverslips were fixed with cold methanol and were then
processed for immunostaining using rabbit antiserum #18 for K18 (Oshima,
1981), anti-K18 mAb CK5 (Sigma Chemical Co.), monoclonal rat anti–
human TNFR2 (Genzyme Diagnostics), FITC-labeled goat anti–rat IgG
(Jackson ImmunoResearch), and rhodamine-labeled goat anti–rabbit (Sigma
Chemical Co.). Cells were visualized with a BioRad MRC 1024 confocal mi-
croscope. Figures were generated with the use of Adobe Photoshop soft-
ware. Single confocal sections were used to visualize colocalized proteins.
Jun N-terminal kinase (JNK) activity was assessed as described (Cav-
igelli et al., 1995). HR9 and HR-7 cells were transfected with 1 
 
m
 
g of
pCMV-M2-FLAG-JNK1 by the calcium phosphate precipitation method.
48 h after the addition of the DNA, the cells were treated with 10 ng/ml of
TNF for the indicated times and assayed for JNK activity. Film signals
were quantified using the NIH Image software. Reporter genes for NF
 
k
 
B
(NF
 
k
 
B-luc) and Ets (E18-luc) were transfected and assayed as described
(Galang et al., 1996). The human 
 
b
 
-actin promoter-driven 
 
LacZ
 
 gene was
included for normalization of transfection efficiency. The cells were
treated with 10 ng/ml of TNF for 6 h, 48 h after the addition of DNA. Lu-
ciferase and 
 
b
 
-galactosidase activity was determined with the Dual-Light
commercial kit (Tropix) with an EGG Berthold luminometer. Relative lu-
ciferase activity was normalized to the 
 
b
 
-galactosidase activity and ex-
pressed as a percentage of the maximum activity.
The K8
 
2
 
 mice were in an FVB/N genetic background (Baribault et al.,
1993, 1994). The K18
 
2
 
 mice (Magin et al., 1998) had a mixed background
(129/Sv,MF1,FVB/N). Littermates without targeted keratin alleles were
used as controls. Male mice (12–14-wk-old) were fasted for 24 h before i.v.
injection of concanavalin A (ConA; 30 mg/kg), dissolved in 200 
 
m
 
l of pyro-
gen-free saline (Tiegs et al., 1992). 8 h after injection, blood was collected
by cardiac puncture. Serum was frozen at 
 
2
 
85
 
8
 
C. The activity of alanine
aminotransferase and aspartate aminotransferase was measured with a
commercial kit (Sigma Chemical Co.) according to the directions of the
Figure 1. Keratin-dependent TNF sensi-
tivity. Cells were incubated for 12 h with
the indicated amounts of TNF in the pres-
ence of 5 mg/ml CHX (a), or for 24 h with
TNF alone (b), CHX alone (c), or dauno-
mycin (DNM; d). Cell survival is ex-
pressed as the mean of triplicate sam-
ples 6 SD. Filled circles and diamonds
represent HR9 and a stable HR9 transfec-
tant expressing wild-type K18, respectively.
Open triangles and squares are HR-1 and
HR-7 clones, respectively, that express
dominant negative K18 (Kulesh et al.,
1989). 
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manufacturer. Livers were fixed in 10% neutral-buffered formalin and
embedded in paraffin. 5-
 
m
 
m thick sections were stained with hematoxylin
and eosin or for detection of apoptosis. Apoptosis was detected with the
ApopTag kit (Oncor) according to the instructions of the manufacturer.
 
Results
 
We first determined the influence of K8 and K18 on the
sensitivity of normal epithelial cells to TNF. HR-1 and HR-7
are two independent subclones of HR9, a mouse parietal
endodermal cell line. Both subclones are deficient in K8
and K18, due to the expression of a disrupting, truncated
form of K18 (Kulesh et al., 1989). Like many cultured cells,
HR9 cells are resistant to killing by TNF unless the induc-
tion of protective proteins is also inhibited by treatment
with cycloheximide (CHX). HR-1 and HR-7 cells were
nearly 100 times more sensitive to the combination of TNF
and CHX than either the parental cells or a control clone
that expresses full-length K18 (Fig. 1 a). None of the cell
lines were killed by TNF alone (Fig. 1 b), and all had similar
sensitivity to CHX-induced cell death (Fig. 1 c). No differ-
ence was observed in the sensitivity of HR-7 cells to apopto-
sis induced by treatment with daunomycin (Fig. 1 d). Simi-
lar results were obtained with multiple clones of the human
breast carcinoma cell line (MDA-MB-435) deficient in K8
RNA expression (data not shown) and stably transfected
subclones which express K8 (Fig. 2 a). In addition, an epi-
thelial cell line established from K8
 
2
 
 ES cells was found to
be more sensitive to TNF than multiple isolates of the same
line that uniformly expressed keratin filaments due to trans-
fected K8 (Fig. 2 b and data not shown).
To determine if K8 and K18 might alter TNF sensitivity
Figure 2. TNF sensitivity of
MDA-MB-435 and CMK8
epithelial cells. a, K8-trans-
fected MDA-MB-435 cells
(filled squares) and K8 nega-
tive cells (open circles) were
treated for 12 h with the indi-
cated amounts of TNF in the
presence of 15 mg/ml of
CHX. Cell survival was de-
termined with the MTT assay.
Data represent the mean 6
SD of three independent
K82 and three K81 clones. b,
the K82 CMK8 epithelial cell
line was transfected with the
mouse K8 gene. TNF sensi-
tivity was determined in the
presence of 2.5 mg/ml of
CHX. Open circles represent
the mean of three keratin
negative clones. Filled squares
represent the mean of three
keratin positive clones.
Figure 3. Binding of K8 and K18 to mem-
bers of the TNFR family. a, GST fusion
proteins (5 mg) of the cytoplasmic do-
mains of different members of the TNFR
family were incubated with 35S-methionine
labeled, in vitro translated, K8 (lanes 1–7)
or K18 (lanes 8–14). Input samples (lanes
15 and 16) represent 1/10 of the amount
incubated with the fusion proteins. b, In
vitro translated K18 (lanes 1 and 2) or
caspase-6–cleaved K18 (lanes 3 and 4) was
incubated with GST-TNFR2 (lanes 2 and
4) or GST-Fas (lane 1). Binding products
were analyzed by SDS-PAGE and fluo-
rography. c–h, Double immunofluorescent
staining of K18 and TNFR2. HR9 (c–e)
and SW13 cells stably transfected with K8
and K18 (f–h) were transiently transfected
with TNFR2 and stained with polyclonal
antiserum (c) or mAb for K18 (f) and
mAb for TNFR2 (d and g). Colocalization
of K18 and TNFR2 (e and h) was visual-
ized in single confocal sections. 
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by direct interaction with TNF receptors, we performed
binding assays of in vitro translated K8 or K18 with GST
fusion proteins of the cytoplasmic domains of different TNF
receptor family members (Mosialos et al., 1995). K8 bound
to the cytoplasmic domains of TNFR2 and LT
 
b
 
R (Fig. 3
a), which both lack death domains. K18 binds TNFR2, and
more weakly with LT
 
b
 
R and inconsistently with TNFR1.
No binding of K8 or K18 was detected with control GST
protein alone, or with the Fas, or HVEM cytoplasmic do-
mains. We localized the portion of K18 responsible for in-
teracting with TNFR2 to the first 238 residues by perform-
ing binding studies with caspase 6-digested K18 (Caulin
et al., 1997; Fig. 3 b). Caspase 6 cleaves K18 after residue
238, resulting in a 26-kD NH
 
2
 
-terminal fragment and a
22-kD COOH-terminal fragment. Incubation of GST-
TNFR2 with K18 partially digested with caspase 6, re-
sulted in enrichment for the larger 26-kD NH
 
2
 
-terminal
fragment and the full-length, uncleaved K18 (Fig. 3 b, lane
4). Thus, the binding of TNFR2 appears specific for the
NH
 
2
 
-terminal half of K18.
We analyzed the possible colocalization of K8 and K18
filaments with TNFR2 by expressing human TNFR2
(Weiss et al., 1997) in HR9 cells. Endogenous keratins and
TNFR2 were detected by confocal microscopy of cells
stained for both mouse K18 and TNFR2. TNFR2 was
found in a diffuse pattern of membrane staining that was
uniformly distributed over the cell surface and in granular,
punctuate structures (Fig. 3 d). K8 and K18 intermediate
filaments were colocalized with some of these granular
forms of TNFR2, particularly at the flattened edges of the
cells (Fig. 3, c and e). A similar staining distribution was
obtained with transfected human adenocarcinoma cell line
SW13, which is devoid of both keratins and vimentin (Sar-
ria et al., 1990). SW13 cells stably transfected with K8 and
K18 genes were transiently transfected with the expression
vector for TNFR2. Colocalization of K18 and TNFR2 was
evident near the flat edges of the cell (Fig. 3, f, g, and h).
These results are consistent with the view that K8 and K18
may bind to TNFR2 within cells. No colocalization of ker-
atins with TNFR1 was detected.
If modulation of apoptosis is mediated by the direct in-
teraction of K8 and K18 with TNF receptors, the presence
of K8 and K18 might affect TNF signaling pathways.
Treatment of HR9 cells with TNF (10 ng/ml) results in a
modest increase in activity of JNK that reaches a maxi-
mum 10 min after ligand exposure and stays constant
for up to 45 min (Fig. 4 a). However, HR-7 cells, with
disrupted K8 and K18 filaments, responded to TNF by
increasing the level and duration of JNK activity. The
maximum induction was 30 min after TNF exposure.
Quantitation indicated that TNF induced a maximum 1.5-
fold activation of JNK in HR9 cells, whereas the activation
in HR-7 cells was more than threefold (Fig. 4 b).
We transfected HR9 and HR-7 cells with luciferase re-
porter genes for NF
 
k
 
B and Ets transcription factors.
NF
 
k
 
B activity was higher after TNF treatment in HR-7
than HR9 cells (Fig. 4 c). In comparison to HR9 cells
treated with 10 ng/ml TNF, tenfold less TNF was needed
to elicit similar NF
 
k
 
B activity in HR-7 cells. In contrast to
NF
 
k
 
B activity, Ets transcriptional activities were similar in
both cell types (Fig. 4 d). These results indicate that TNF-
mediated NF
 
k
 
B activation is moderated by the presence
of K8 and K18. Both the JNK and NF
 
k
 
B responses indi-
cate that K8 and K18 may moderate TNF-initiated intra-
cellular signaling.
To test the functional significance of K8 and K18 in cell
death that is mediated by membrane receptors in vivo, we
used the mouse model of ConA-induced liver damage
Figure 4. Downstream signaling in-
duced by TNF. a, JNK activity after
stimulation with TNF (10 ng/ml) in
HR9 and HR-7 cells. Autoradio-
graphic exposures of GST-c-jun af-
ter incubation with immunoprecipi-
tated JNK and radioactive ATP are
shown. b, Densitometric analysis of
the films shown in a. Filled bars,
HR9; hatched bars, HR-7. c, Nor-
malized luciferase activity of NFkB
and Ets2 (d) reporter genes in HR9
(black bars) and HR-7 (hatched
bars) after stimulation with 1 or 10
ng/ml of TNF. Results are repre-
sented as a percentage of the maxi-
mum activity. 
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(Tiegs et al., 1992). ConA-induced liver apoptosis is medi-
ated by activated T cells through TNF (Mizuhara et al.,
1994). Both TNFR1 and TNFR2 are required for liver in-
jury (Kusters et al., 1997). We injected ConA into wild-type,
K8
 
2
 
, and K18
 
2
 
 mice. Both strains of keratin-deficient mice
were more sensitive to liver damage initiated by ConA (Fig.
5, a and b). Serum levels of both liver transaminases were
two to three times higher in treated K8
 
2
 
 or K18
 
2
 
 mice than
wild-type littermates (
 
P
 
 
 
,
 
 0.028). Whereas K8
 
2
 
 mice have
slightly elevated, but nonpathological, levels of these en-
zymes in untreated animals (Baribault et al., 1994), the lev-
els caused by ConA were 50–100 times higher than un-
treated mice, reflective of the massive liver damage.
Hepatocyte apoptosis precedes liver failure in ConA-
induced hepatitis (Leist et al., 1995). To evaluate apoptosis
in the livers of K8 and K18 null mice, we examined sections
of the livers of ConA-treated animals for degraded nuclear
DNA. Livers from K8
 
2
 
 (Fig. 5 c) or K18
 
2
 
 (Fig. 5 d) mice
treated with ConA had large apoptotic areas throughout
the tissue. The livers of treated control mice had smaller fo-
cal areas of apoptotic cells (Fig. 5 e). Standard histology re-
vealed massive hemorrhage and the presence of inflamma-
tory lymphocytes in the three types of mice (Fig. 5, g and h).
Apoptotic areas were also recognized by weakly staining cy-
toplasm and pyknotic nuclei (Fig. 5 f).
In summary, decreasing levels of K8 and K18 in cultured
epithelial cells increases their cellular sensitivity to killing
by TNF. K8 and K18 bind the cytoplasmic domains of
TNFR2, colocalize with TNFR2 within cells, and moder-
ate the TNF-dependent activation of JNK and the NF
 
k
 
B
 
transcription factor. Mice without K8 or K18 are more
sensitive to TNF-mediated apoptotic liver damage.
 
Discussion
 
Specialized epidermal keratins clearly serve a structural func-
tion (Fuchs and Weber, 1994). However, neither the midges-
tational developmental defects nor the inflammatory bowel
disease that develops in adult K8
 
2
 
 mice appear to be consis-
tent with a simple structural function for K8 and K18.
Whereas other keratins may partially compensate for the ab-
sence of K8 or K18 in some tissues of null mice, the interme-
diate filaments of trophectoderm at the blastocyst stage and
of adult liver are composed exclusively of K8 and K18. The
trophectoderm of K8
 
2
 
 and K18
 
2
 
 blastocysts withstands the
stress of normal implantation. K8
 
2
 
 embryos die at midgesta-
tion when placental function becomes crucial. Perhaps kera-
tin-dependent resistance to maternally presented TNF may
also be important for trophoblast derivative function beyond
12 d. The inflammatory bowel disease which develops in
adult K8
 
2
 
 mice resembles the effects caused by the targeted
mutation of the T cell receptor or other cytokines. These
models indicate the participation of the immune system (Sar-
tor, 1994). In humans, increased levels of TNF are found in
patients with Crohn’s disease (Braegger et al., 1992), a form
of inflammatory bowel disease, and the use of TNF inhibitors
has been successful for treating this disease (van Dullemen et
al., 1995). We suggest the colorectal hyperplasia and inflam-
mation of K8
 
2
 
 mice may stem from increased sensitivity to
TNF. This phenotype is not found in K18
 
2
 
 mice, perhaps be-
Figure 5. ConA-induced liver dam-
age and apoptosis. a and b, The ac-
tivity of liver transaminases in the
serum of K182 (a) or K82 (b) mice.
Serum activity of aspartate ami-
notransferase (black bars) and as-
partate aminotransferase (hatched
bars) was determined 8 h after i.v
injection of 30 mg/kg ConA. c–h,
Apoptosis in livers from K182 mice
(c), K82 (d), and control mice (e
and f) challenged with ConA was
detected by terminal deoxynucleo-
tidyl transferase TUNEL method. f,
Represents a magnification of the
insert area in e, g and h. Hematoxy-
lin and eosin staining. f and g, Rep-
resent serial sections of the same
liver. Note the presence of pyknotic
nuclei in g, in areas that are
TUNEL positive (f). Infiltrating
lymphocytes in this area are indi-
cated by arrows in h. 
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cause of compensation with K19 or K20 from the intestine
(Magin et al., 1998). The organization of K8 intermediate fil-
aments, with either K18, K19, or K20 as a partner, may be
sufficient to protect the colon from the effects of TNF.
The disruption or absence of keratins in the liver leads to
mild hepatitis and increased sensitivity to the hepatotoxin
acetaminophen (Baribault et al., 1994; Ku et al., 1996).
Based on an increased sensitivity of K8
 
2
 
 hepatocytes to per-
fusion, microcystin exposure and partial hepatectomy, K8
and K18 have been suggested to be necessary for the struc-
tural integrity of hepatocytes (Ku et al., 1995; Loranger et
al., 1997; Toivola et al., 1998). However, TNF acts as both a
growth factor and apoptotic stimulus in liver. It is expressed
in liver during acute and chronic liver damage (Czaja et al.,
1989) and after exposure to high levels of acetaminophen
(Blazka et al., 1995). Neutralizing anti-TNF antibodies sig-
nificantly reduce liver injury caused by acetaminophen, but
inhibit liver regeneration after partial hepatectomy (Aker-
man et al., 1992; Blazka et al., 1996). The increased sensitiv-
ity of K8
 
2
 
 liver cells to TNF may be the basis for poor toler-
ance of partial hepatectomy and poor survival of explanted
hepatocytes. A distinctive feature of K8, K18, and K19 is
persistent or induced expression in carcinomas in compari-
son to other keratins. The keratin-dependent resistance to
TNF may be the selective advantage responsible for the
persistence of K8 and K18 expression in carcinoma cells.
Resistance of epithelia to apoptosis is likely important dur-
ing common inflammatory responses.
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